Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

3.320 USD -0.020 (-0.60%)
Official Closing Price Updated: 4:19 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,100
Open 3.370
Bid (Size) 3.150 (14)
Ask (Size) 3.860 (5)
Prev. Close 3.340
Today's Range 3.250 - 3.370
52wk Range 3.020 - 7.380
Shares Outstanding 11,100,453
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announces today that they have entered into a research agreement... 
From PR Newswire
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announces today that they have entered into a research agreement... 
From PR Newswire

Performance

YTD
-42.76%
-42.76%
1 Month
-12.63%
-12.63%
3 Month
-26.55%
-26.55%
6 Month
-26.71%
-26.71%
1 Year
-16.79%
-16.79%

More News

Read More
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
From PR Newswire
Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER program
From PR Newswire
Galmed Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on Thursday August 6
From PR Newswire
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
From PR Newswire
Week in Review: Baidu Raising $2 Billion for New China Biopharma
From ChinaBio® Today
Week In Review: Baidu Raising $2 Billion For New China Biopharma
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Gannex Pharma, an Ascletis Subsidiary, Announces NASH Partnership
From ChinaBio® Today
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
Tags CYTK DRIO IMMU
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Tags PSTX IOVA QGEN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.